The assessment of the safety and efficacy of Basalin (Insulin glargine) in patients with type 2 diabetes: a postmarketing survey

Authors
Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2020
This article has no abstract
Epistemonikos ID: 98d3470de055d13481532e6bfc469cf83d4a386f
First added on: Feb 25, 2021